[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 23, Issue 4 (Winter 2022) ::
J Gorgan Univ Med Sci 2022, 23(4): 26-32 Back to browse issues page
Association of Serum Magnesium Level with Glycemic Control, Serum Lipids and Renal Function in Type 2 Diabetes Mellitus and Pre-Diabetic Patients
Farzad Sharifnezhad1 , Samira Eshghinia2 , Hamideh Akbari * 3
1- Medical Student, Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Science, Gorgan, Iran.
2- Assistant Professor, Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
3- Assistant Professor, Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran. , dr.akbari.h@gmail.com
Abstract:   (421 Views)
Background and Objective: Diabetes is one of the most common non-communicable diseases with debilitating complications and mortality rate those results from insulin deficiency, resistance to it or both. The role of nutrition and some micronutrients in the development and progression of diabetes has been investigated. Studies have shown that Magnesium deficiency can reduce insulin secretion and cell resistance. This study was done to determine the association of serum Magnesium level with glycemic control, serum lipids and renal function in type 2 diabetes mellitus and pre-diabetic patients.
Methods: This case-control study was done on 70 patients with type 2 diabetes, pre-diabetes and 35 healthy individuals. Fasting glucose, HbA1c, lipid profile, creatinine and Magnesium were determined.
Results: Serum Magnesium level in diabetic and pre-diabetic patients were significantly lower than control group (P<0.05). Serum Magnesium level had reverses correlation with HbA1c in diabetic patients. Serum Magnesium level had reverse correlation with glycemic index (FBS, 2hpp) and creatinine in control group (P<0.05) were evaluated in all groups but there was no significant correlation between Renal function test (Cr, eGFR) and serum Mg level.
Conclusion: Serum Magnesium levels in diabetics and pre-diabetics were lower than healthy individuals and had reverse correlation with HbA1c in diabetic patients.
Keywords: Diabetes Mellitus [MeSH], Magnesium [MeSH], Prediabetic State [MeSH], Blood Glucose [MeSH], Creatinine [MeSH],
Article ID: Vol23-50
Full-Text [PDF 498 kb]   (802 Downloads)    
Type of Study: Original Articles | Subject: Endocrinology
References
1. Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F, et al. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine (Baltimore). 2016 Feb; 95(7): e2756. DOI: 10.1097/MD.0000000000002756 [DOI] [PubMed]
2. Fang C, Wang X, Wu W, Gu X, Ye T, Deng H, et al. Association of Serum Magnesium Level with Odds of Prediabetes and Diabetes in a Southern Chinese Population: a Prospective Nested Case-Control Study. Biol Trace Elem Res. 2016 Aug; 172(2): 307-14. DOI: 10.1007/s12011-015-0594-y [DOI] [PubMed]
3. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016 Jan; 65(1): 3-13. DOI: 10.2337/db15-1028 [DOI] [PubMed]
4. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res. 2010 May; 134(2): 119-29. DOI: 10.1007/s12011-009-8465-z [DOI] [PubMed]
5. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci. 2019 Mar; 20(6): 1351. DOI: 10.3390/ijms20061351 [DOI] [PubMed]
6. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnes Res. 2011 Dec; 24(4): 163-80. DOI: 10.1684/mrh.2011.0292 [DOI] [PubMed]
7. Zhang X, Del Gobbo LC, Hruby A, Rosanoff A, He K, Dai Q, et al. The Circulating Concentration and 24-h Urine Excretion of Magnesium Dose- and Time-Dependently Respond to Oral Magnesium Supplementation in a Meta-Analysis of Randomized Controlled Trials. J Nutr. 2016 Mar; 146(3): 595-602. DOI: 10.3945/jn.115.223453 [DOI] [PubMed]
8. Chutia H, Lynrah KG. Association of Serum Magnesium Deficiency with Insulin Resistance in Type 2 Diabetes Mellitus. J Lab Physicians. 2015 Jul-Dec; 7(2): 75-78. DOI: 10.4103/0974-2727.163131 [DOI] [PubMed]
9. Pokharel DR, Khadka D, Sigdel M, Yadav NK, Kafle R, Sapkota RM, et al. Association of serum magnesium level with poor glycemic control and renal functions in Nepalese patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2017 Nov; 11 (Suppl 1): S417-S423. DOI: 10.1016/j.dsx.2017.03.028 [DOI] [PubMed]
10. Silva AP, Mendes F, Fragoso A, Jeronimo T, Pimentel A, Gundlach K, et al. Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease. J Diabetes Complications. 2016 Mar; 30(2): 275-80. DOI: 10.1016/j.jdiacomp.2015.11.006 [DOI] [PubMed]
11. Li H, Sun S, Chen J, Xu G, Wang H, Qian Q. Genetics of Magnesium Disorders. Kidney Dis (Basel). 2017 Dec; 3(3): 85-97. DOI: 10.1159/000477730 [DOI] [PubMed]
12. Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M, de la Peña JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest. 2008 Jun; 38(6): 389-96. DOI: 10.1111/j.1365-2362.2008.01957.x [DOI] [PubMed]
13. Leibowitz D, Maaravi Y, Stessman-Lande I, Jacobs JM, Gilon D, Stessman J. Cardiac structure and function and renal insufficiency in the oldest old. Clin Cardiol. 2012 Dec; 35(12): 764-69. DOI: 10.1002/clc.22049 [DOI] [PubMed]
14. Wälti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly. 2003 May; 133(19-20): 289-92. [PubMed]
15. Yadav C, Manjrekar PA, Agarwal A, Ahmad A, Hegde A, Srikantiah RM. Association of Serum Selenium, Zinc and Magnesium Levels with Glycaemic Indices and Insulin Resistance in Pre-diabetes: a Cross-Sectional Study from South India. Biol Trace Elem Res. 2017 Jan; 175(1): 65-71. DOI: 10.1007/s12011-016-0766-4 [DOI] [PubMed]
16. Sun L, Yu Y, Huang T, An P, Yu D, Yu Z, et al. Associations between ionomic profile and metabolic abnormalities in human population. PLoS One. 2012; 7(6): e38845. DOI: 10.1371/journal.pone.0038845 [DOI] [PubMed]
17. Xu J, Xu W, Yao H, Sun W, Zhou Q, Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population. PLoS One. 2013; 8(2): e56750. DOI: 10.1371/journal.pone.0056750 [DOI] [PubMed]
18. Erasmus RT, Olukoga AO, Alanamu RA, Adewoye HO, Bojuwoye B. Plasma magnesium and retinopathy in black African diabetics. Trop Geogr Med. 1989 Jul; 41(3): 234-37. [PubMed]
19. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999 Oct; 159(18): 2151-69. DOI: 10.1001/archinte.159.18.2151 [DOI] [PubMed]
20. White JR Jr, Campbell RK. Magnesium and diabetes: a review. Ann Pharmacother. 1993 Jun; 27(6): 775-80. DOI: 10.1177/106002809302700619 [DOI] [PubMed]
21. Bertinato J, Wang KC, Hayward S. Serum Magnesium Concentrations in the Canadian Population and Associations with Diabetes, Glycemic Regulation, and Insulin Resistance. Nutrients. 2017 Mar; 9(3): 296. DOI: 10.3390/nu9030296 [DOI] [PubMed]
22. Ramadass S, Basu S, Srinivasan AR. SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes Metab Syndr. 2015 Jan-Mar; 9(1): 42-45. DOI: 10.1016/j.dsx.2014.04.024 [DOI] [PubMed]
23. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011 Mar; 13(3): 281-84. DOI: 10.1111/j.1463-1326.2010.01332.x [DOI] [PubMed]
24. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010 Feb; 87(2): 261-66. DOI: 10.1016/j.diabres.2009.11.003 [DOI] [PubMed]
25. Musabayane CT. The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovasc J Afr. 2012 Sep; 23(8): 462-68. DOI: 10.5830/CVJA-2012-025 [DOI] [PubMed]
26. Norris KC, Smoyer KE, Rolland C, Van der Vaart J, Grubb EB. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018 Feb; 19(1): 36. DOI: 10.1186/s12882-018-0821-9 [DOI] [PubMed]
27. Ritz E, Miltenberger-Miltenyi G, Wagner J, Rychlik I. Diabetes--renal function--what are the special problems? Basic Res Cardiol. 1998; 93 (Suppl 2): 125-30. DOI: 10.1007/s003950050237 [DOI] [PubMed]
28. Khan FA, Al Jameil N, Arjumand S, Khan MF, Tabassum H, Alenzi N, et al. Comparative Study of Serum Copper, Iron, Magnesium, and Zinc in Type 2 Diabetes-Associated Proteinuria. Biol Trace Elem Res. 2015 Dec; 168(2): 321-29. DOI: 10.1007/s12011-015-0379-3 [DOI] [PubMed]
29. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol. 2005 Jun; 63(6): 429-36. DOI: 10.5414/cnp63429 [DOI] [PubMed]
30. Nasri H, Baradaran HR. Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy. 2008; 109(7): 302-6. [PubMed]
31. Srinivasan AR, Niranjan G, Kuzhandai Velu V, Parmar P, Anish A. Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels. Diabetes Metab Syndr. 2012 Oct-Dec; 6(4): 187-89. DOI: 10.1016/j.dsx.2012.09.001 [DOI] [PubMed]
32. Wolide AD, Zawdie B, Alemayehu T, Tadesse S. Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study. BMC Endocr Disord. 2017 Oct; 17(1): 64. DOI: 10.1186/s12902-017-0217-z [DOI] [PubMed]
33. Yu L, Zhang J, Wang L, Li S, Zhang Q, Xiao P, et al. Association between serum magnesium and blood lipids: influence of type 2 diabetes and central obesity. Br J Nutr. 2018 Aug; 120(3): 250-58. DOI: 10.1017/S0007114518000685 [DOI] [PubMed]
34. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications. 2000 Sep-Oct; 14(5): 272-76. DOI: 10.1016/s1056-8727(00)00127-6 [DOI] [PubMed]
35. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 1995; 41(5): 347-59. [PubMed]
36. Maier JA. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci (Lond). 2012 May; 122(9): 397-407. DOI: 10.1042/CS20110506 [DOI] [PubMed]
37. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. 2017 Oct; 30(5): 621-33. DOI: 10.1111/jhn.12454 [DOI] [PubMed]
38. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran. 2014 Jul; 28: 67. [PubMed]
39. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res. 2009 Dec; 22(4): 235-46. DOI: 10.1684/mrh.2009.0187 [DOI] [PubMed]
40. Djurhuus MS, Gram J, Petersen PH, Klitgaard NA, Bollerslev J, Beck-Nielsen H. Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest. 1995 Oct; 55(6): 549-58. DOI: 10.1080/00365519509075394 [DOI] [PubMed]
41. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995 Jul; 48(7): 927-40. DOI: 10.1016/0895-4356(94)00200-a [DOI] [PubMed]
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifnezhad F, Eshghinia S, Akbari H. Association of Serum Magnesium Level with Glycemic Control, Serum Lipids and Renal Function in Type 2 Diabetes Mellitus and Pre-Diabetic Patients. J Gorgan Univ Med Sci. 2022; 23 (4) :26-32
URL: http://goums.ac.ir/journal/article-1-3933-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 4 (Winter 2022) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4414